STEVEN A MCCORMICK, MD
Medical Practice at 14 St, New York, NY
License number
New York 178016
Category
Medical Practice
Type
Anatomic Pathology
Address
Address
310 E 14Th St FL 3RD, New York, NY 10003
Phone
(212) 979-4156
(212) 677-1284 (Fax)
(212) 677-1284 (Fax)
Personal information
See more information about STEVEN A MCCORMICK at radaris.comName
Address
Phone
53 Hampton Grn, Staten Island, NY 10312
PO Box 15, Chateaugay, NY 12920
9 Pidgeon Ct, Manorville, NY 11949
63 Hoffman Dr, Latham, NY 12110
13 Ingersoll Rd, Saratoga Springs, NY 12866
Organization information
See more information about STEVEN A MCCORMICK at bizstanding.comSTEVEN A. MCCORMICK, M.D., PC
310 E 14 St, New York, NY 10003
Registration:
May 9, 1989
State ID:
1351254
Business type:
DOMESTIC PROFESSIONAL CORPORATION
Steven A Mccormick Md, 310 E 14 St, New York, NY 10003 (Physical)
Professional information
See more information about STEVEN A MCCORMICK at trustoria.com
President / Ceo At Bogner Industrial Group, Inc
President / Ceo At Bogner Industrial Group, Inc
Position:
President / CEO at Bogner Industrial Group, Inc.
Location:
Greater New York City Area
Industry:
Facilities Services
Work:
Bogner Industrial Group, Inc.
- New Brunswick, New Jersey since Oct 2004
-
President / CEO
Stryker Orthopaedics
Jan 2005 - Jan 2007
-
Facilities Project Manager (Consultant)
McCain Foods, USA
Apr 1999 - Oct 2004
-
Engineering Manager
Sunshine Biscuits
Jan 1994 - Apr 1999
-
Project Manager
Continental Baking Company
1992 - 1994
-
Project Manager
Stroehmann Bakeries
1986 - 1992
-
Project Manager
Skills:
Plant Maintenance, Plant Engineering, Facilities Engineering, Manufacturing Operations Management, Cost Justification, Energy Efficiency, Water Efficiency, Energy Services, HVAC, Electrical, Energy Audits, Solar, Facilities Management, Maintenance Management, Electricians, Construction, Manufacturing, Energy Conservation, Refrigeration, Solar Energy, Automation, Energy Management, Project Engineering, Continuous Improvement, Industrial Engineering, Maintenance & Repair, Project Management, Root Cause Analysis, Preventive Maintenance, Engineering Management, Factory, Capital Projects, Management, Project Planning, Engineering, Mechanical Engineering, Building Automation, Commissioning, Inspection, Contract Management, Process Engineering, Air Conditioning, PLC, Troubleshooting, Energy, Lean Manufacturing, Contractors, Electrical Engineering, Renewable Energy, ISO
Interests:
Hunting, Bow Hunting, Fishing, Golf, Hiking, Cooking
Steven Andrew McCormick, New York NY
Steven Andrew McCormick, New York NY
Specialties:
Pathology, Anatomic Pathology, Clinical Pathology/Laboratory Medicine
Work:
New York Eye And Ear Infirmary
310 E 14Th St, New York, NY 10003
310 E 14Th St, New York, NY 10003
Education:
West Virginia University (1984)
Dr. Steven A Mccormick, New York NY - MD (Doctor of Medicine)
Dr. Steven A Mccormick, New York NY - MD (Doctor of Medicine)
Specialties:
Anatomic Pathology
Address:
310 E 14Th St, New York 10003
(212) 979-4156 (Phone), (212) 677-1284 (Fax)
(212) 979-4156 (Phone), (212) 677-1284 (Fax)
Certifications:
Anatomic Pathology, 1988
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
West Virginia University School Of Medicine
Graduated: 1984
W Va University Hospital
Graduated: 1988
West Virginia University School Of Medicine
Graduated: 1984
W Va University Hospital
Graduated: 1988
Epidermal Melanocyte Culture Formulations
Epidermal Melanocyte Culture Formulations
US Patent:
7132279, Nov 7, 2006
Filed:
Jul 26, 2005
Appl. No.:
11/190631
Inventors:
Dan-Ning Hu - Bayside NY, US
Steven McCormick - New York NY, US
Steven McCormick - New York NY, US
Assignee:
New York Eye & Ear Infirmary - New York NY
International Classification:
C12N 5/00, C12N 5/02, A01N 63/00, A01N 65/00
US Classification:
435325, 435405, 435408
Abstract:
The present invention provides methods and compositions for providing graft recipients with epidermal melanocytes. Specifically, the methods and compositions of the invention provide for populations of epidermal melanocytes that may be isolated from a patient and cultured in vitro to generate a proliferating population of epidermal melanocytes that exhibit growth, migration and melanin production. The invention is based on the discovery of a culture medium composed of natural components, for culturing epidermal melanocytes that exhibit increased proliferative capacity, migratory behaviors and melanin production. The invention provides novel in vitro methods for culturing epidermal melanocytes, including those isolated from the skin of a healthy subject, to generate a proliferating population of epidermal melanocytes. The methods and compositions of the invention may be used for transplantation to treat patients having hypopigmentation or depigmentation skin disorders.
Epidermal Melanocyte Culture Formulations
Epidermal Melanocyte Culture Formulations
US Patent:
2005006, Mar 24, 2005
Filed:
Sep 24, 2003
Appl. No.:
10/670971
Inventors:
Dan-Ning Hu - Bayside NY, US
Steven McCormick - New York NY, US
Steven McCormick - New York NY, US
International Classification:
C12N005/08, C12N005/02
US Classification:
435366000, 435404000
Abstract:
The present invention provides methods and compositions for providing graft recipients with epidermal melanocytes. Specifically, the methods and compositions of the invention provide for populations of epidermal melanocytes that may be isolated from a patient and cultured in vitro to generate a proliferating population of epidermal melanocytes that exhibit growth, migration and melanin production. The invention is based on the discovery of a culture medium composed of natural components, for culturing epidermal melanocytes that exhibit increased proliferative capacity, migratory behaviors and melanin production. The invention provides novel in vitro methods for culturing epidermal melanocytes, including those isolated from the skin of a healthy subject, to generate a proliferating population of epidermal melanocytes. The methods and compositions of the invention may be used for transplantation to treat patients having hypopigmentation or depigmentation skin disorders.
Chondrocyte Culture Formulations
Chondrocyte Culture Formulations
US Patent:
2007017, Aug 2, 2007
Filed:
Oct 6, 2006
Appl. No.:
11/539464
Inventors:
Dan-Ning Hu - Bayside NY, US
Steven McCormick - New York NY, US
Steven McCormick - New York NY, US
International Classification:
A61K 35/12, C12N 5/08, C12N 5/06
US Classification:
424093700, 435325000, 435366000
Abstract:
The present invention provides methods and compositions for providing graft recipients with chondrocytes. Specifically, the methods and compositions of the invention provide for populations of chondrocytes that may be isolated from a patient and cultured in vitro to generate a proliferating population of chondrocytes that exhibit great proliferation capacity. The invention is based, in part, on the discovery of a culture medium having serum, insulin and various growth factors for culturing chondrocytes that exhibit increased proliferative capacity. The invention provides novel in vitro methods for culturing chondrocytes, including those isolated from the cartilage of a healthy subject, to generate a proliferating population of chondrocytes. The methods and compositions of the invention may be used for transplantation to treat patients having damaged cartilage.
System And Methods For Laser Treatment Of Ocular Tissue
System And Methods For Laser Treatment Of Ocular Tissue
US Patent:
2004017, Sep 9, 2004
Filed:
Mar 6, 2003
Appl. No.:
10/383124
Inventors:
Robert Alfano - Bronx NY, US
Tapan Gayen - Brooklyn NY, US
Steven McCormick - New York NY, US
Richard Rosen - New York NY, US
Alvin Katz - Bronx NY, US
Howard Savage - Ossining NY, US
Tapan Gayen - Brooklyn NY, US
Steven McCormick - New York NY, US
Richard Rosen - New York NY, US
Alvin Katz - Bronx NY, US
Howard Savage - Ossining NY, US
International Classification:
A61B018/20
US Classification:
606/004000, 606/008000
Abstract:
A system and method for exposing ocular tissue to a beam of electromagnetic radiation tuned to an NIR wavelength between about 1380 nm and about 1600 nm in the water absorption band. The laser energy is absorbed by the water, which in turn, transfers the energy to collagen molecules. The helical collagen molecules partially denature and then re-nature to form a weld across the region of the tissues to be joined. In a preferred embodiment, the electromagnetic radiation originates from a laser. The lasers may be Cr doped crystals, Erbium fibers, and alloys of semiconductor laser diodes.